Request for information, reporting of pharmacy benefits and prescription drug costs
Prescription drug expenditure reporting requirements that apply for group health plans and health insurance issuers
Prescription drug expenditure reporting requirements
The U.S. Treasury Department and IRS—along with the Office of Personnel Management, the Department of Labor, and the Department of Health and Human Services—today released for publication in the Federal Register a “request for information” on issues related to certain prescription drug expenditure reporting requirements that apply for group health plans and health insurance issuers offering group or individual health insurance coverage.
The request for information [PDF 250 KB] (as published in the Federal Register on June 23, 2021) relates to certain reporting requirements under provisions of the “Consolidated Appropriations Act, 2021.” Those reporting requirements primarily relate to prescription drug expenditures and require group health plans and health insurance issuers offering group or individual health insurance coverage to submit relevant information.
The provisions also require the governmental departments to issue biannual public reports on prescription drug reimbursements under group health plans and individual health insurance coverage, prescription drug pricing trends, and the impact of prescription drug costs on premium rates (but aggregated in such a way so that no drug or plan specific information will be made public).
Comments made in response to the request for information are due by a date that is 30 days after it appears in the Federal Register (scheduled for June 23, 2021).
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 3712, 1801 K Street NW, Washington, DC 20006.